Stock INIT INITIATOR PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Financials Initiator Pharma A/S

Equities

INIT

DK0060775872

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
9.05 SEK +1.12% Intraday chart for Initiator Pharma A/S -2.69% -2.06%
May. 10 Initiator Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 Initiator Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 98.33 259 211.9 325.1 309.4 - -
Enterprise Value (EV) 1 98.33 238 172.8 300.8 197.4 221.4 202.4
P/E ratio -11.1 x -12.3 x -5.54 x -14.1 x 3.4 x -14.5 x 14.5 x
Yield - - - - - - -
Capitalization / Revenue - - - - 2.24 x - 5.95 x
EV / Revenue - - - - 1.43 x - 3.89 x
EV / EBITDA -9.36 x -10.3 x -4.14 x -11.1 x 1.61 x -10.4 x 10.3 x
EV / FCF -12.2 x -6.98 x -5.28 x -20.4 x 2.27 x -9.23 x 10.7 x
FCF Yield -8.2% -14.3% -18.9% -4.91% 44.1% -10.8% 9.39%
Price to Book 6.82 x 7.4 x - - - - -
Nbr of stocks (in thousands) 27,706 43,772 52,362 52,472 52,916 - -
Reference price 2 3.549 5.917 4.046 6.196 5.783 5.783 5.783
Announcement Date 2/19/21 2/18/22 2/17/23 2/23/24 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - 138 - 52
EBITDA 1 -10.5 -23.06 -41.74 -27.03 122.8 -21.25 19.6
EBIT 1 -10.53 -23.07 -41.74 -27.03 122.8 -21.25 19.6
Operating Margin - - - - 88.99% - 37.69%
Earnings before Tax (EBT) 1 -10.24 -24.24 -44.13 -27.71 123 -24 20
Net income 1 -8.697 -21.06 -38.46 -22.87 90 -24 20
Net margin - - - - 65.22% - 38.46%
EPS 2 -0.3200 -0.4800 -0.7300 -0.4400 1.700 -0.4000 0.4000
Free Cash Flow 1 -8.064 -34.1 -32.7 -14.78 87 -24 19
FCF margin - - - - 63.04% - 36.54%
FCF Conversion (EBITDA) - - - - 70.85% - 96.94%
FCF Conversion (Net income) - - - - 96.67% - 95%
Dividend per Share - - - - - - -
Announcement Date 2/19/21 2/18/22 2/17/23 2/23/24 - - -
1DKK in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 21.1 39.1 24.3 112 88 107
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 -8.06 -34.1 -32.7 -14.8 87 -24 19
ROE (net income / shareholders' equity) - - -111% -101% 149% -22% 19%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 0.5200 0.8000 - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 2/19/21 2/18/22 2/17/23 2/23/24 - - -
1DKK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
INITIATOR PHARMA A/S Stock Initiator Pharma A/S
-2.06% 44.76M
MODERNA, INC. Stock Moderna, Inc.
+25.83% 46.56B
LONZA GROUP AG Stock Lonza Group AG
+45.38% 41.67B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.69% 41.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+30.52% 32.4B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+22.30% 28.18B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.1B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+49.25% 14.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+49.18% 13.74B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.45% 12.17B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. INIT Stock
  4. Financials Initiator Pharma A/S